NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
Advanced Micro Devices
AMD
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
WST West Pharmaceutical Services
- 232.340
- +9.780+4.39%
Close Feb 28 16:00 ET
- 220.730
- -11.610-5.00%
Post 20:01 ET
16.80BMarket Cap34.73P/E (TTM)
233.120High223.370Low1.86MVolume223.680Open222.560Pre Close429.96MTurnover2.59%Turnover Ratio34.73P/E (Static)72.30MShares399.87852wk High6.26P/B16.68BFloat Cap197.01052wk Low0.81Dividend TTM71.81MShs Float471.428Historical High0.35%Div YieldTTM4.38%Amplitude3.184Historical Low231.422Avg Price1Lot Size
West Pharmaceutical Services Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.92%2.89B | 2.30%748.8M | -0.07%746.9M | -6.86%702.1M | -2.96%695.4M | 2.18%2.95B | 3.29%732M | 8.81%747.4M | -2.27%753.8M | -0.47%716.6M |
| Operating revenue | -1.92%2.89B | 2.30%748.8M | -0.07%746.9M | -6.86%702.1M | -2.96%695.4M | 2.18%2.95B | 3.29%732M | 8.81%747.4M | -2.27%753.8M | -0.47%716.6M |
| Cost of revenue | 4.07%1.89B | 4.72%475.2M | 5.03%482.2M | 2.10%472.1M | 4.47%465.2M | 3.99%1.82B | 1.61%453.8M | 9.60%459.1M | 2.80%462.4M | 2.27%445.3M |
| Gross profit | -11.57%998.5M | -1.65%273.6M | -8.19%264.7M | -21.07%230M | -15.15%230.2M | -0.62%1.13B | 6.14%278.2M | 7.57%288.3M | -9.36%291.4M | -4.67%271.3M |
| Operating expense | -3.37%407.6M | -4.24%103.8M | -6.07%99M | -4.19%100.5M | 1.16%104.3M | 12.36%421.8M | 6.69%108.4M | 31.91%105.4M | 9.38%104.9M | 5.20%103.1M |
| Selling and administrative expenses | -4.22%338.5M | -5.22%85.3M | -6.18%83.5M | -6.11%83M | 0.81%86.7M | 11.52%353.4M | 5.02%90M | 34.24%89M | 8.47%88.4M | 3.12%86M |
| Research and development costs | 1.02%69.1M | 0.54%18.5M | -5.49%15.5M | 6.06%17.5M | 2.92%17.6M | 16.92%68.4M | 15.72%18.4M | 20.59%16.4M | 14.58%16.5M | 17.12%17.1M |
| Operating profit | -16.47%590.9M | 0.00%169.8M | -9.40%165.7M | -30.56%129.5M | -25.15%125.9M | -7.02%707.4M | 5.79%169.8M | -2.76%182.9M | -17.33%186.5M | -9.86%168.2M |
| Net non-operating interest income expense | -12.63%16.6M | -31.71%5.6M | -33.90%3.9M | 8.70%2.5M | 76.92%4.6M | 778.57%19M | 583.33%8.2M | 942.86%5.9M | 264.29%2.3M | 236.84%2.6M |
| Non-operating interest income | -30.00%19.6M | -48.94%4.8M | -47.73%4.6M | -20.00%4M | 29.17%6.2M | 449.02%28M | 224.14%9.4M | 486.67%8.8M | 1,150.00%5M | 1,500.00%4.8M |
| Non-operating interest expense | -66.67%3M | -166.67%-800K | -75.86%700K | -44.44%1.5M | -27.27%1.6M | 13.92%9M | -29.41%1.2M | 31.82%2.9M | 50.00%2.7M | 0.00%2.2M |
| Other net income (expense) | 22.54%-22M | -7.14%-10.5M | -183.33%-5.1M | 15.38%-3.3M | 75.97%-3.1M | 63.64%-28.4M | 70.30%-9.8M | 96.48%-1.8M | -230.00%-3.9M | -516.13%-12.9M |
| Gain on sale of security | -8.51%-10.2M | 54.69%-2.9M | -127.78%-4.1M | -566.67%-2M | -33.33%-1.2M | -329.27%-9.4M | -204.76%-6.4M | -357.14%-1.8M | -118.75%-300K | -123.08%-900K |
| Special income (charges) | 52.17%-9.9M | -386.67%-7.3M | 107.14%300K | 61.76%-1.3M | 86.21%-1.6M | 37.27%-20.7M | 95.07%-1.5M | -44.83%-4.2M | -409.09%-3.4M | -1,350.00%-11.6M |
| -Less：Restructuring and merger&acquisition | 620.00%2.6M | 258.33%1.9M | -285.71%-1.3M | 433.33%1M | 233.33%1M | -101.87%-500K | -104.65%-1.2M | -53.33%700K | 76.92%-300K | -62.50%300K |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | -68.42%600K | ---- | ---- | ---- | ---- | --1.9M |
| -Write off | -23.96%7.3M | 100.00%5.4M | -71.43%1M | -80.00%300K | ---- | 54.84%9.6M | -41.30%2.7M | 150.00%3.5M | --1.5M | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | --0 | --0 | --0 | ---11.6M | --0 | --0 | ---2.2M | ---9.4M |
| Other non- operating income (expenses) | -211.76%-1.9M | 84.21%-300K | -130.95%-1.3M | ---- | 25.00%-300K | 103.46%1.7M | -280.00%-1.9M | 108.57%4.2M | -166.67%-200K | ---400K |
| Income before tax | -16.12%585.5M | -1.96%164.9M | -12.03%164.5M | -30.39%128.7M | -19.32%127.4M | 2.66%698M | 30.69%168.2M | 37.30%187M | -18.62%184.9M | -15.92%157.9M |
| Income tax | -12.10%107.5M | 6.67%36.8M | 10.20%32.4M | -37.07%21.9M | -30.51%16.4M | 6.63%122.3M | 19.38%34.5M | 44.12%29.4M | -21.27%34.8M | 11.32%23.6M |
| Earnings from equity interest net of tax | -16.95%14.7M | -39.39%2M | 5.41%3.9M | -10.00%4.5M | -24.56%4.3M | -14.49%17.7M | 3.13%3.3M | -22.92%3.7M | -9.09%5M | -20.83%5.7M |
| Net income | -16.97%492.7M | -5.04%130.1M | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M | -19.45%140M |
| Net income continuous Operations | -16.97%492.7M | -5.04%130.1M | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M | -19.45%140M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -16.97%492.7M | -5.04%130.1M | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M | -19.45%140M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -16.97%492.7M | -5.04%130.1M | -15.69%136M | -28.24%111.3M | -17.64%115.3M | 1.28%593.4M | 33.01%137M | 33.75%161.3M | -17.72%155.1M | -19.45%140M |
| Basic earnings per share | -15.41%6.75 | -3.24%1.79 | -13.82%1.87 | -26.92%1.52 | -16.49%1.57 | 1.40%7.98 | 34.06%1.85 | 33.95%2.17 | -17.79%2.08 | -19.66%1.88 |
| Diluted earnings per share | -15.10%6.69 | -2.73%1.78 | -13.55%1.85 | -26.70%1.51 | -16.22%1.55 | 1.94%7.88 | 34.56%1.83 | 34.59%2.14 | -16.94%2.06 | -19.21%1.85 |
| Dividend per share | 5.19%0.81 | 5.00%0.21 | 5.26%0.2 | 5.26%0.2 | 5.26%0.2 | 5.48%0.77 | 5.26%0.2 | 5.56%0.19 | 5.56%0.19 | 5.56%0.19 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |